United States · FDA National Drug Code directory
Sodium Polystyrene Sulfonate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 35573-108_609a9733-cc0e-48ed-b2e1-8d765a4650d7
- Product NDC
- 35573-108
- Form
- SUSPENSION
- Composition / generic term
- sodium polystyrene sulfonate
- Labeler
- Burel Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251218
- Source listing expiry
- 20271231
Source-listed ingredients
- SODIUM POLYSTYRENE SULFONATE — 15 g/60mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BOTTLE, UNIT-DOSE in 1 CARTON (35573-108-14) / 60 mL in 1 BOTTLE, UNIT-DOSE (35573-108-13) · 35573-108-14
- 473 mL in 1 BOTTLE (35573-108-57) · 35573-108-57
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →